A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of anti-emetic drug Aprepitant upon the
combination chemotherapy of nedaplatin and docetaxel for non-small cell lung cancer (NSCLC).